drugset / Trial / NCT02262572
Relative Bioavailability of Telmisartan and HCTZ in Two Experimental Formulations Compared to the Standard Formulation Telmisartan and HCTZ in Healthy Female and Male Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
Study to assess the comparative pharmacokinetics of telmisartan/HCTZ in two new formulations based on sodium salt compared to the present commercial formulation (MicardisPlus®)
Timeline
- Start
- 2003-04
- Primary completion
- 2003-08
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hydrochlorothiazide | Unknown | 12.5 mg | — |
| Subject | Telmisartan | Other / unclassified | 80 mg | — |
Indications
No indication recorded.